Thornton & Ross acquires five brands from GSK

GSK is transferring five brands to Thornton & Ross

Huddersfield-based OTC medicine manufacturer Thornton & Ross has acquired five brands from GlaxoSmithKline – four skin care brands and one cough remedy – in a deal it hopes will drive growth in the pharmacy sector.

The brands being acquired from GSK through the new contract are: Oilatum, an emollient that is currently focused in the paediatric market; antiseptic brand Savlon; itch relief cream Eurax; Polytar, a shampoo used for scalp conditions including psoriasisl and Tixylix, a children’s cough liquid brand.

Thornton & Ross, which has been part of the Germany-based STADA pharmaceutical group since 2013, said completion of the deal was expected by August 2019.

The acquisition follows “over a decade of consistent growth,” the company said, adding that it is “currently enjoying double-digit growth”.

Roger Scarlett-Smith, head and executive vice president of Thornton & Ross, said: “These acquisitions demonstrate our determination to work with and support the pharmacy sector and our ambition to be the leading company in consumer health.”

“We very much believe that the strong relationship we have in the pharmacy sector is crucial to our ongoing success.”

Recommended

Pharma companies accused of breaking competition law

Revenue up, profits down at Superdrug




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.